- Simplicity, Versatility, Targeted Delivery
- We offer a versatile catheter system for use with both standard and developing therapeutic agents.
- RenovoRx was honored at TiEcon on May 18th, 2013 as one of the only three winning startups in the Life Sciences vertical.
RenovoRx is a medical device company headquartered in Silicon Valley, California.
We are developing solutions for targeted delivery of therapeutic and diagnostic agents
to selected sites in the peripheral vascular system.
RenovoCath™ Catheter System
We do catheters differently. This video shows the RenovoCath RC120 special features and the role these features play in delivering therapeutic agents to targeted regions.
In the News
RenovoRx Attending “Y-90: The Complete Course”
“Y-90: The Complete Course” is the only educational opportunity dedicated to Authorized User and Advanced practice of Y-90 treatment of hepatic malignancies. It is the most comprehensive and challenging radioembolization learning experience available to interventional radiologists and trainees. RenovoRx will … Continue readingRead More
Visit RenovoRx at the Gastrointestinal Cancers Symposium
The Gastrointestinal Cancers Symposium is a high-profile, specialized oncology event designed for the exchange of the latest research and science in cancers of the pancreas, small bowel, and hepatobiliary tract; colon and rectum; and esophagus and stomach. RenovoRx will be … Continue readingRead More
RenovoCath™ RC120 Receives FDA 510(k) Clearance
Menlo Park, CA (October 30, 2014) – RenovoRx, a leading developer of innovative solutions for targeted delivery of fluids to selected sites in the vascular system, today announced the company has received FDA 510(k) clearance of its flagship product, the … Continue readingRead More
Optimized design for targeted balloon placement
Contact delivery of therapeutic agents